Ameliorating amyotrophic lateral sclerosis

New England Journal of Medicine

Volumn 362, Issue 10, 2010, Pages 953-954

  Rowland, Lewis P ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MICRORNA; MYOD PROTEIN; MYOGENIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DOWN REGULATION; MOTONEURON; MUSCLE ATROPHY; NERVE FIBER; NEUROMUSCULAR SYNAPSE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 77949408590     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr0912229     Document Type: Article

References (6)

1. Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009;65:Suppl 1:S3-S9.
2. Williams AH, Valdez G, Moresi V, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009;326:1549-54.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
4. Griffiths-Jones S, Grocock RJ, van Dongen S, Baterman A, Enright AJ. miRBase: microDNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006;34:Database issue:D140-D144.
5. van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 2007;117:2369-76.
6. Ferrer I, Martinez A, Boluda S, Parchi P, Barrachina M. Brain banks: benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies. Cell Tissue Bank 2008;9:181-94.